Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Broad-spectrum penicillins / penicillinase-resistant penicillins. |
| Generic Name : | Ampicillin, flucloxacillin |
| Drug description : | Magnapen Capsules: black/ turquoise capsules marked MAGNAPEN. Magnapen Syrup: powder for reconstitution. Magnapen Injection: powder in vial. |
| Presentation : | Magnapen Capsules: Ampicillin 250 mg , flucloxacillin 250 mg . Magnapen Syrup: Ampicillin 125 mg , flucloxacillin 125 mg per 5 mL. Magnapen Injection: Ampicillin and flucloxacillin in equal parts 500 mg . |
| Indications : | Severe infections where the causative organism is unknown. Mixed infections involving beta- lactamase-producing staphylococci present. Typical indications include: in general practice, chest infections, ENT infections, skin and soft tissue infections, and infections in patients whose underlying pathology places them at special risk; in hospital (prior to laboratory results being available), severe respiratory tract infections, postoperative chest and wound infections, septic abortion, puerperal fever, septicaemia, prophylaxis in major surgery, infections in patients receiving immunosuppressive therapy. |
| Adult Dosage : | Magnapen Capsules and Magnapen Syrup: 1 capsule or 10 ml syrup four times daily / - 1 hour before meals. Magnapen Injection: 500 mg four times daily. |
| Child Dosage : | Magnapen Capsules and Magnapen Syrup: Under 10 years, 5 ml syrup four times daily / - 1 hour before meals. Magnapen Injection: Under 2 years, quarter adult dose; 2 - |
| Special Precautions : | Infectious mononucleosis. |
| Adverse Reactions : | Hypersensitivity reactions. GI disturbances. Rarely cholestatic jaundice. |
| Manufacturer : | CP Pharmaceuticals |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org